Form 4: Roivant Sciences President & COO Eric Venker Reports Stock Transactions
SEC Form 4
Eric Venker, President & COO of Roivant Sciences, reports the acquisition and disposal of common shares and stock options.
Summary
- On October 20, 2024, Eric Venker disposed of 10,945 common shares at a price of $11.92 to cover tax obligations related to RSU vesting.
- On October 21, 2024, Venker acquired 100,000 common shares through the exercise of stock options at a price of $3.85.
- Also on October 21, 2024, Venker sold 100,000 common shares at a weighted average price of $11.65.
- Following these transactions, Venker directly owns 617,470 common shares.
- Venker also holds stock options for 12,426,234 common shares with an exercise price of $3.85, vesting from April 20, 2022.
Sentiment
Score: 6
Explanation: Neutral sentiment as the transactions are a mix of stock option exercises and sales, which is common for executives. The sale to cover tax obligations is a standard practice.
Positives
- The exercise of stock options demonstrates Venker's confidence in Roivant Sciences.
- The sale of shares at $11.65 is significantly higher than the exercise price of $3.85, indicating a profit for Venker.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, allowing investors to gauge management's sentiment and alignment with shareholder interests.
Comparison to Industry Standards
- Form 4 filings are a regulatory requirement for company insiders in the United States, ensuring transparency in stock transactions.
- Similar filings are required in other jurisdictions to monitor insider trading activities.
- The information disclosed in Form 4 filings is used by investors to assess the confidence of company insiders in the company's prospects.
Stakeholder Impact
- The transactions may have a minor impact on shareholders as they provide insight into management's actions.
- The disposal of shares to cover tax obligations is a standard practice and should not significantly impact stakeholders.
Key Dates
| Date | Description |
|---|---|
| 04/20/2022 | Vesting commencement date for stock options. |
| 10/20/2024 | Disposal of 10,945 common shares. |
| 10/21/2024 | Exercise of stock options and sale of 100,000 common shares. |
| 10/22/2024 | Date of Form 4 signature. |
| 04/19/2032 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.